ArticleTissue engineering. Part B, Reviews2008
Stem cells for heart cell therapies.
Article in Tissue engineering. Part B, Reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- A scalable and tunable thermoreversible polymer for 3D human pluripotent stem cell biomanufacturing.iScience · 2022Article
- Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.Stem cell research & therapy · 2020Article
- A novel tool for suspension culture of human induced pluripotent stem cells: Lysophospholipids as a cell aggregation regulator.Regenerative therapy · 2019Article
- Automated real-time monitoring of human pluripotent stem cell aggregation in stirred tank reactors.Scientific reports · 2019Article
- Thermoreversible Hyaluronic Acid-PNIPAAm Hydrogel Systems for 3D Stem Cell Culture.Advanced healthcare materials · 2018Article
- Aggregate and Microcarrier Cultures of Human Pluripotent Stem Cells in Stirred-Suspension Systems.Methods in molecular biology (Clifton, N.J.) · 2016Article
- Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart.Current gene therapy · 2016Review
- Potential for Stem Cell-Based Periodontal Therapy.Journal of cellular physiology · 2016Review
- Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation.Tissue engineering. Part B, Reviews · 2015Review
- Current achievements and future perspectives in whole-organ bioengineering.Stem cell research & therapy · 2015Review
- Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.Journal of visualized experiments : JoVE · 2015Article
- Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.Stem cell reviews and reports · 2015Review
- Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013.Annals of biomedical engineering · 2014Review
- A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production.Stem cell reports · 2014Article
- Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells.Heart rhythm · 2013Article
- Defining synthetic surfaces for human pluripotent stem cell culture.Cell regeneration (London, England) · 2013Review
- Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors.Tissue engineering. Part C, Methods · 2012Article
- Systematic analysis of embryonic stem cell differentiation in hydrodynamic environments with controlled embryoid body size.Integrative biology : quantitative biosciences from nano to macro · 2012Article
- MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.American journal of physiology. Heart and circulatory physiology · 2011Article
- The multiparametric effects of hydrodynamic environments on stem cell culture.Tissue engineering. Part B, Reviews · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Myocardial infarction-induced heart failure is a prevailing cause of death in the United States and most developed countries. The cardiac tissue has extremely limited regenerative potential, and heart transplantation for reconstituting the function of damaged heart is severely hindered mainly due to the scarcity of donor organs. To that end, stem cells with their extensive proliferative capacity and their ability to differentiate toward functional cardiomyocytes may serve as a renewable cellular source for repairing the damaged myocardium. Here, we review recent studies regarding the cardiogenic potential of adult progenitor cells and embryonic stem cells. Although large strides have been made toward the engineering of cardiac tissues using stem cells, important issues remain to be addressed to enable the translation of such technologies to the clinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.